<DOC>
	<DOC>NCT01543945</DOC>
	<brief_summary>The purpose of this study is to compare the incidence of Postoperative nausea and vomiting between the intervention group who received multimodal antiemetic management and the control group who did not get this protocol.</brief_summary>
	<brief_title>Prevention Post Operative Nausea Vomiting in Ambulatory Gynecologic Laparoscopy</brief_title>
	<detailed_description />
	<mesh_term>Nausea</mesh_term>
	<mesh_term>Vomiting</mesh_term>
	<mesh_term>Postoperative Nausea and Vomiting</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dimenhydrinate</mesh_term>
	<mesh_term>Antiemetics</mesh_term>
	<mesh_term>Ondansetron</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<criteria>Ambulatory gynecologic laparoscopy Age 1845 years ASA class 12 The patients who take opioid, steroid, pyschotics or antiemetic drug within 24 hours before surgery History of antiemetic, anesthetic and analgesic drugs allergy Pregnancy or breast feeding Body mass index &gt;34 kg/square metre</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>Postoperative Nausea and Vomiting</keyword>
	<keyword>Ambulatory</keyword>
	<keyword>Gynecologic laparoscopy</keyword>
	<keyword>Incidence of postoperative nausea and vomiting.</keyword>
</DOC>